Deprenyl augmentation for treating negative symptoms of schizophrenia: a double-blind, controlled study.
Jungerman, T
Deprenyl augmentation for treating negative symptoms of schizophrenia: a double-blind, controlled study. [electronic resource] - Journal of clinical psychopharmacology Dec 1999 - 522-5 p. digital
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
0271-0749
10.1097/00004714-199912000-00006 doi
Adult
Double-Blind Method
Female
Humans
Male
Middle Aged
Monoamine Oxidase Inhibitors--therapeutic use
Placebo Effect
Schizophrenia--drug therapy
Selegiline--therapeutic use
Deprenyl augmentation for treating negative symptoms of schizophrenia: a double-blind, controlled study. [electronic resource] - Journal of clinical psychopharmacology Dec 1999 - 522-5 p. digital
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
0271-0749
10.1097/00004714-199912000-00006 doi
Adult
Double-Blind Method
Female
Humans
Male
Middle Aged
Monoamine Oxidase Inhibitors--therapeutic use
Placebo Effect
Schizophrenia--drug therapy
Selegiline--therapeutic use